Product Program year 2021 Source: CMS Open Payments

Naprelan

Drug Analgesic

NDC 52427-272-01

Open in the dashboard

General payments

$112,514

7,260 payments

Research payments

$0

0 payments

Through program year 2021, $112,514 in general payments and $0 in research payments were reported against Naprelan (Analgesic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $112,514 7,260

Breakdown

Who paid General payments · program year 2021
  1. Almatica Pharma LLC $112,514 7,260 payments
Top recipients General payments · program year 2021
  1. Amr Morsy Interventional Pain Medicine · Rockwall, TX $192 <1% · 9 payments
  2. Steven Villarreal Physician Assistant, Medical · San Antonio, TX $191 <1% · 11 payments
  3. Philip Doh Pain Medicine · Los Angeles, CA $186 <1% · 12 payments
  4. Michelle Lerner Physician Assistant, Medical · Danbury, CT $178 <1% · 12 payments
  5. Thomas Espinoza Physician Assistant, Medical · San Antonio, TX $168 <1% · 9 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Nurse Practitioner, Family Nurse Practitioner $15,200 14% · 497 practitioners
  2. Neurology Psychiatry & Neurology $14,464 13% · 451 practitioners
  3. Physician Assistant $12,137 11% · 354 practitioners
  4. Interventional Pain Medicine Pain Medicine $10,105 9% · 260 practitioners
  5. Pain Medicine Anesthesiology $9,647 9% · 240 practitioners

The top 5 of 94 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $13,916 12% · 366 recipients
  2. New York $12,557 11% · 325 recipients
  3. Florida $10,821 10% · 299 recipients
  4. California $9,415 8% · 266 recipients
  5. Georgia $6,329 6% · 228 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

7,260 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record